Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity. Drugs like Ozempic work by mimicking the hormone that releases insulin from your pancreas, ...

Weight regain is common after stopping GLP-1s, as appetite increases and the body tries to return you to your previous weight ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...

The MarketWatch News Department was not involved in the creation of this content. New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker ...

SALT LAKE CITY, Dec. 17, 2025 /PRNewswire/ -- Shed, the wellness brand known for health and weight-loss solutions, has launched three new products to support long-term health: Tirzepatide Microdose ...

Noom CEO Geoff Cook discusses the company's move into longevity health, microdose GLP-1, and new diabetes program on 'Mornings with Maria.' ...

Discover how a stacked GLP-1 Microdose and Sermorelin therapy blend science with glamour for transformation and longevity. These days, more and more celebrities are walking the red carpet and the ...

Since 2022, the GLP-1 drug market has nearly quadrupled in size as more patients use them to help treat diabetes and obesity. We expect the market to reach $180 billion by 2034 based on the drug ...

Microdose GLP-1 medication — eligible patients are prescribed small, personalized doses, which are conveniently shipped to the member’s door. At-home Biomarkers test kit — 17 advanced lab markers that ...

Ash, a leading provider of at-home testing and care delivery, today announced the expansion of its partnership with Noom, the global platform for preventive health and longevity solutions. The ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.